Genetic characterization of vocal fold lesions: Leukoplakia and Carcinoma

Laryngoscope

Volumn 122, Issue 2, 2012, Pages 336-342

  Bartlett, Rebecca S ^b   Heckman, W Wesley ^b   Isenberg, Jason ^c   Thibeault, Susan L ^b   Dailey, Seth H ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

^c Department of Otolaryngology ^*  (United States)

Author keywords

genetic expression; laryngeal keratosis; Leukoplakia; Level of Evidence: 4; vocal fold tumorigenesis

Indexed keywords

GELATINASE A; GELATINASE B; INTERSTITIAL COLLAGENASE; TUMOR MARKER;

ADULT; AGED; ANGIOGENESIS; ARTICLE; CANCER GROWTH; CANCER PATIENT; CARCINOGENESIS; CLINICAL ARTICLE; DEGRADATION; EPDR1 GENE; EXTRACELLULAR MATRIX; FEASIBILITY STUDY; GENE; GENE EXPRESSION; GENETIC ANALYSIS; HIGH RISK PATIENT; HUMAN; HUMAN TISSUE; IGF 1 GENE; INVASIVE CARCINOMA; LARYNGEAL BIOPSY; LARYNX CARCINOMA; LEUKOPLAKIA; MALE; MALIGNANT TRANSFORMATION; MMP 2 GENE; NUCLEOTIDE SEQUENCE; OBSERVATIONAL STUDY; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RELIABILITY; S100A4 GENE; UPREGULATION;

AGED; CARCINOMA; CROSS-SECTIONAL STUDIES; DNA, NEOPLASM; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC PREDISPOSITION TO DISEASE; HUMANS; IMMUNOHISTOCHEMISTRY; LARYNGEAL NEOPLASMS; LEUKOPLAKIA; MALE; MIDDLE AGED; REAL-TIME POLYMERASE CHAIN REACTION; TUMOR MARKERS, BIOLOGICAL; VOCAL CORDS;

EID: 84856273887     PISSN: 0023852X     EISSN: 15314995     Source Type: Journal    
DOI: 10.1002/lary.22417     Document Type: Article

References (20)

1. Kowalski LP, Franco EL, Sobrinho JDA, Oliveira BV, Pontes PL,. Prognostic factors in laryngeal cancer patients submitted to surgical treatment. J Surg Oncol 2006; 48: 87-95.
2. Isenberg JS, Crozier DL, Dailey SH,. Institutional and comprehensive review of laryngeal leukoplakia. Ann Otol Rhinol Laryngol 2008; 117: 74-79. (Pubitemid 351219761)
3. Ricci G, Molini E, Faralli M, Simoncelli C,. Retrospective study on precancerous laryngeal lesions: a clinicopathologic study with long-term follow-up. Acta Otorhinolaryngol Ital 2003; 23: 362-367.
4. Zeitels SM,. Premalignant epithelium and microinvasive cancer of the vocal fold: the evolution of phonomicrosurgical management. Laryngoscope 1995; 105: 1-51.
5. Belbin TJ, Singh B, Barber I, et al. Molecular classification of head and neck squamous cell carcinoma using cDNA microarrays. Cancer Res 2002; 62: 1184-1190. (Pubitemid 34160307)
6. Manes S, Llorente M, Lacalle RA, et al. The matrix metalloproteinase-9 regulates the insulin-like growth factor-triggered autocrine response in DU-145 carcinoma cells. J Biol Chem 1999; 274: 6935-6945.
7. Egeblad M, Werb Z,. New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2002; 2: 161-174. (Pubitemid 37328786)
8. Samantaray S, Sharma R, Chattopadhyaya TK, Datta Gupta S, Ralhan R,. Increased expression of MMP-2 and MMP-9 in esophageal squamous cell carcinoma. J Cancer Res Clin Oncol 2004; 130: 37-44. (Pubitemid 38161246)
9. Timar J, Csuka O, Remenar E, Repassy G, Kasler M,. Progression of head and neck squamous cell cancer. Cancer Metastasis Rev 2005; 24: 107-127. (Pubitemid 40576067)
10. Sherbet GV, Lakshmi MS,. S100A4 (MTS1) calcium binding protein in cancer growth, invasion and metastasis. Anticancer Res 1998; 18: 2415-2421. (Pubitemid 28386529)
11. Keirsebilck A, Bonne S, Bruyneel E, et al. E-cadherin and metastasin (mts-1/S100A4) expression levels are inversely regulated in two tumor cell families. Cancer Res 1998; 58: 4587-4591. (Pubitemid 28480620)
12. Nimmrich I, Erdmann S, Melchers U, et al. The novel ependymin related gene UCC1 is highly expressed in colorectal tumor cells. Cancer Lett 2001; 165: 71-79. (Pubitemid 32206660)
13. Seandel M, Noack-Kunnmann K, Zhu D, Aimes RT, Quigley JP,. Growth factor-induced angiogenesis in vivo requires specific cleavage of fibrillar type I collagen. Blood 2001; 97: 2323-2332. (Pubitemid 32291478)
14. Yoshiji H, Harris SR, Raso E, et al. Mammary carcinoma cells over-expressing tissue inhibitor of metalloproteinases-1 show enhanced vascular endothelial growth factor expression. Int J Cancer 1998; 75: 81-87. (Pubitemid 28113981)
15. Clark ES, Whigham AS, Yarbrough WG, Weaver AM,. Cortactin is an essential regulator of matrix metalloproteinase secretion and extracellular matrix degradation in invadopodia. Cancer Res 2007; 67: 4227-4235. (Pubitemid 46815069)
16. Roepman P, Wessels LF, Kettelarij N, et al. An expression profile for diagnosis of lymph node metastases from primary head and neck squamous cell carcinomas. Nat Genet 2005; 37: 182-186.
17. Rosenthal EL, Matrisian LM,. Matrix metalloproteases in head and neck cancer. Head Neck 2006; 28: 639-648. (Pubitemid 44025114)
18. Yu Q, Stamenkovic I,. Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-β and promotes tumor invasion and angiogenesis. Genes Dev 2000; 14: 163-176. (Pubitemid 30070982)
19. Lu SL, Reh D, Li AG, et al. Overexpression of transforming growth factor β1 in head and neck epithelia results in inflammation, angiogenesis and epithelial hyperproliferation. Cancer Res 2004; 64: 4405-4410. (Pubitemid 38856909)
20. O-Charoenrat P, Rhys-Evans PH, Eccles SA,. Expression of matrix metalloproteinases and their inhibitors correlates with invasion and metastasis in squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg 2001; 127: 813-820. (Pubitemid 32619361)